Animal Models of Behçet’s Disease

  • Ehud Baharav
  • Abraham Weinberger
  • Felix Mor
  • Ilan Krause


Animal models for Behçet’s disease (BD) can be divided according to the proposed etiological paradigms. These include environmental pollution and infectious (bacterial and viral) models, as well as various autoimmune and transgenic animal models. The environmental pollution model, though resembles the multisystem symptoms of BD, has limitations to become utilized as a model for the disease since it is difficult to produce and the onset of symptoms appears erratically in a wide time range. The Streptococcal models have similarity only to the eye involvement in BD. This model is simple to induce with high rate of homogeneity. The HSV model has multisystem manifestations resembling BD; it has a moderate reproducibility. The autoimmune model utilizing S-Ag is a monosymptomatic model of BD-like uveitis. This model is easy to induce, and extensive studies elucidated some of the immunological characteristics of BD including the paradigm of anti-HLA autoimmunity. The α-tropomyosin model shares some clinical features of BD. This model has a potential to become a useful autoimmune model for BD. The only published trial to establish a transgenic model for BD did not show any significant similarity to the human disease except hyper-responsiveness of neutrophils.


Infectious Autoimmunity Herpes simplex Air pollution Heat shock proteins Uveitis 


  1. 1.
    Hori Y, Miyazawa S, Nishiyama S et al (1979) Experimental Behçet’s disease and ultrastructural X-ray microanalysis of pathological tissues. J Dermatol 6:31–37PubMedGoogle Scholar
  2. 2.
    Bang D, Honma T, Saito T et al (1987) Electron microscopic observation on dark endothelial cells in erythema nodosum-like lesions of Behçet’s disease with ultrastructural X-ray spectroanalysis. J Toxicol Sci 12:321–328PubMedCrossRefGoogle Scholar
  3. 3.
    Kaneko F, Oyama N, Nishibu A (1997) Streptococcal infection in the pathogenesis of Behçet’s disease and clinical effects of minocycline on the disease symptoms. Yonsei Med J 38:444–454PubMedGoogle Scholar
  4. 4.
    Saenz A, Ausejo M, Shea B, et al. (2000) Pharmacotherapy for Behçet’s syndrome. Cochrane Database Syst Rev CD001084 Vol. 2Google Scholar
  5. 5.
    Sohn S, Lee ES, Bang D et al (1998) Behçet’s disease-like symptoms induced by the Herpes simplex virus in ICR mice. Eur J Dermatol 8:21–23PubMedGoogle Scholar
  6. 6.
    Sohn S, Lee ES, Lee S (2001) The correlation of MHC haplotype and development of Behçet’s disease-like symptoms induced by herpes simplex virus in several inbred mouse strains. J Dermatol Sci 26:173–181PubMedCrossRefGoogle Scholar
  7. 7.
    Bang D, Choi B, Kwon HJ et al (2008) Rebamipide affects the efficiency of colchicine for the herpes simplex virus-induced inflammation in a Behçet’s disease mouse model. Eur J Pharmacol 598:112–117PubMedCrossRefGoogle Scholar
  8. 8.
    Choi B, Hwang Y, Kwon HJ et al (2008) Tumor necrosis factor alpha small interfering RNA decreases herpes simplex virus-induced inflammation in a mouse model. J Dermatol Sci 52:87–97PubMedCrossRefGoogle Scholar
  9. 9.
    Javid B, MacAry PA, Lehner PJ (2007) Structure and function: heat shock proteins and adaptive immunity. J Immunol 179:2035–2040PubMedGoogle Scholar
  10. 10.
    Hu W, Hasan A, Wilson A et al (1998) Experimental mucosal induction of uveitis with the 60-kDa heat shock protein-derived peptide 336–351. Eur J Immunol 28:2444–2455PubMedCrossRefGoogle Scholar
  11. 11.
    de Smet MD, Bitar G, Mainigi S et al (2001) Human S-antigen determinant recognition in uveitis. Invest Ophthalmol Vis Sci 42:3233–3238PubMedGoogle Scholar
  12. 12.
    Kurhan-Yavuz S, Direskeneli H, Bozkurt N et al (2000) Anti-MHC autoimmunity in Behçet’s disease: T cell responses to an HLA-B-derived peptide cross-reactive with retinal-S antigen in patients with uveitis. Clin Exp Immunol 120:162–166PubMedCrossRefGoogle Scholar
  13. 13.
    Mor F, Weinberger A, Cohen IR (2002) Identification of alpha-tropomyosin as a target self-antigen in Behçet’s syndrome. Eur J Immunol 32:356–365PubMedCrossRefGoogle Scholar
  14. 14.
    Baharav E, Mor F, Halpern M et al (2004) Lactobacillus GG bacteria ameliorate arthritis in Lewis rats. J Nutr 134:1964–1969PubMedGoogle Scholar
  15. 15.
    Ohno S, Ohguchi M, Hirose S et al (1982) Close association of HLA-Bw51 with Behçet’s disease. Arch Ophthalmol 100:1455–1458PubMedCrossRefGoogle Scholar
  16. 16.
    Takeno M, Kariyone A, Yamashita N et al (1995) Excessive function of peripheral blood neutrophils from patients with Behçet’s disease and from HLA-B51 transgenic mice. Arthritis Rheum 38:426–433PubMedCrossRefGoogle Scholar
  17. 17.
    Direskeneli H, (2001) Behçet’s disease infectious aetiology, new autoantigens, and HLA-B51. Ann Rheum Dis 60:996–1002PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Ehud Baharav
  • Abraham Weinberger
  • Felix Mor
  • Ilan Krause
    • 1
  1. 1.Department of Medicine E, Rabin Medical CenterBeilinson HospitalPetah-TiqvaIsrael

Personalised recommendations